Despite their strong efficiency in MF, the use of BET inhibitor molecules has initially been limited due to dose-limiting toxicities including thrombocytopenia, fatigue, nausea, vomiting, and diarrhea [141]. Here, DNER is linked to Thrombocytopenia.